L-3,4-dihydroxyphenylalanine increases the quantal size of exocytotic dopamine release in vitro

Journal of Neurochemistry

Volumn 66, Issue 2, 1996, Pages 629-636

  Pothos, Emmanuel ^a   Desmond, Mark ^a   Sulzer, David ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Amperometry; L DOPA; PC12 cells; Quantal release; Quantal size; Reverse transport

Indexed keywords

DOPAMINE RECEPTOR; LEVODOPA; NOMIFENSINE; POTASSIUM;

AMPEROMETRY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG MECHANISM; EXOCYTOSIS; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT;

ANIMALIA;

EID: 0029670630     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66020629.x     Document Type: Article

References (36)

1. Abercrombie E. D., Bonatz A. E., and Zigmond M. J. (1990) Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525, 36-44.
2. Alvarez de Toledo G , Fernandez-Chacon R., and Fernandez J. M. (1993) Release of secretory products during transient vesicle fusion. Nature 363, 554-558.
3. Attwell D., Barbour B., and Szatkowski M. (1993) Nonvesicular release of neurotransmitter. Neuron 11, 401-407.
4. Bauerfeind R., Regnier-Vigouroux A., Flatmark T., and Huttner W. B. (1993) Selective storage of acetylchoune, but not catecholamines, in neuroendocrine synaptic-like microvesicles of early endosomal origin. Neuron 11, 105-121.
5. Bernath S. and Zigmond M. J. (1990) Dopamine enhances striatal GABA release via an influence on the GABA uptake system. Biogenic Amines 7, 465-473.
6. Buu N. T. (1989) Vesicular accumulation of dopamine following L-DOPA administration. Biochem. Pharmacol 38, 1787-1792.
7. Chen T. K., Luo G., and Ewing A. G. (1994) Amperometric monitoring of stimulated catecholamine release from rat pheochromocytoma (PC12) cells at the zeptomole level. Anal. Chem. 66, 3031-3035.
8. Chow R. H., Von Rüden L., and Neher E. (1992) Delay in vesicle fusion revealed by electrochemical monitoring of single secretory events in adrenal chromaffin cells. Nature 356, 60-63.
9. Dluzen D. E. and Kratko F. T. (1992) L-DOPA infusion mode differentially affects corpus striatal dopamine efflux in the presence of reserpine. J. Neural Transm. 89, 197-207.
10. 3H] aminobutyric acid release from cultured mouse cerebral cortex neurons by sulphur-containing excitatory amino acid transmitter candidates: receptor activation mediates two distinct mechanisms of release. J. Neurochem. 57, 1388-1397.
11. Garris P. A., Ciolkowski E. L., Pastore P., and Wightman R. M. (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14, 6084-6093.
12. Greene L. A. and Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which responds to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424-2428.
13. Greene L. A., Sobeih M. M., and Teng K. K. (1991) Methodologies for the culture and experimental use of the PC12 rat pheochromocytoma cell line, in Cell Culture of Neocortex and Basal Forebrain from Postnatal Rats (Banker G. and Goslin K., eds), pp. 208-226. MIT Press, Cambridge.
14. Johnson R. G. (1988) Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport. Physiol. Rev. 68, 232-307.
15. Kawagoe K. T., Zimmerman J. B., and Wightman R. M. (1993) Principles of voltammetry and microelectrode surface states. J. Neurosci. Methods 48, 225-240.
16. Keller R. W., Kuhr W. G., Wightman R. M., and Zigmond M. J. (1988) The effect of L-DOPA on in vivo dopamine release from nigrostriatal bundle neurons. Brain Res. 447, 191-194.
17. Koshimura K., Ohue T., Akiyama Y., Itoh A., and Miwa S. (1992) L-DOPA administration enhances exocytic dopamine release in vivo in the rat striatum. Life Sci. 51, 747-755.
18. Lavoie M. P., Palmatier M., Gentile F. T., Kaplan F. A., Fiore D. M., Hazlett T. F., Bell W. J., and Flanagan T. R. (1993) Two PC12 pheochromocytoma lines sealed in hollow fiber-based capsules tonically release L-DOPA in vitro. Cell Transplant. 2, 163-173.
19. Leszczyszyn D. J., Jankowski J. A., Viveros O. H., Diliberto E. J. Jr., Near J. A., and Wightman R. M. (1991) Secretion of catecholamines from individual adrenal medullary chromaffin cells. J. Neurochem. 56, 1855-1863.
20. Levi G. and Raiteri M. (1993) Carrier-mediated release of neurotransmitters. Trends Neurosci. 16, 415-419.
21. Lonart G. and Zigmond M. J. (1991) High glutamate concentrations evoke Ca++-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J. Pharmacol. Exp. Ther. 256, 1132-1138.
22. Ng K. Y., Chase T. N., Colburn R. W., and Kopin I. J. (1970) L-DOPA-induced release of cerebral monoamines. Science 170, 76-77.
23. Pani L., Cessa G. L., Carboni S., Portas C. M., and Rossetti Z. L. (1990) Brain dialysis and dopamine: does the extracellular concentration of dopamine reflect synaptic release? Eur. J. Pharmacol. 180, 85-90.
24. Ramachandran B., Houben K , Rozenberg Y. Y., Haigh J. R., Varpetian A., and Howard B. D. (1993) Differential expression of transporters for norepinephrine and glutamate in wild type, vanant, and WNT1-expressing PC12 cells. J. Biol. Chem. 268, 23891-23897.
25. Rayport S., Sulzer D., Shi W.-X., Sawasdikosol S., Monaco J., Batson D., and Rajendran G. (1992) Identified postnatal mesolimbic dopamine neurons in cell culture: morphology and electrophysiology. J. Neurosci. 12, 4264-4280.
26. Ryan T. A. and Smith S. J. (1995) Vesicle pool mobilization during action potential firing at hippocampal synapses. Neuron 14, 983-989.
27. Schroeder T. J., Jankowski J. A., Kawagoe K. T., Wightman R. M., Lefrou C., and Amatore C. (1992) Analysis of diffusional broadening of vesicular packets of catecholamines released from biological cells during exocytosis. Anal. Chem. 64, 3077-3083.
28. Schubert D., LaCorbiere M., Klier F. G., and Steinbach J. H. (1980) The modulation of neurotransmitter synthesis by steroid hormones and insulin. Brain Res. 190, 67-79.
29. Schuldiner S. (1994) A molecular glimpse of vesicular monoamine transporters. J. Neurochem. 62, 2067-2078.
30. Schwartz E. A. (1987) Depolarization without calcium can release γ-aminobutyric acid from a retinal neuron. Science 238, 350-355.
31. Snyder G. L. and Zigmond M. J. (1990) The effects of L-DOPA on in vitro dopamine release from striatum. Brain Res. 508, 181-187.
32. Sulzer D., Maidment N. T., and Rayport S. (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60, 527-535.
33. Sulzer D., Chen T. K., Lau Y. Y., Kristensen H., Rayport S., and Ewing A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15, 4102-4108.
34. Taglialatela S., Amoroso S., Kaparos G., Maurano F., Di Renzo G. F., and Annunziato L. (1988) Membrane events and ionic processes involved in dopamine release from tuberinfundibular neurons. 1. Effect of the inhibition of the Na+, K+-adenosine triphosphatase pump by ouabain. J. Pharmacol. Exp. Ther. 246, 682-688.
35. Wagner J. A. (1985) Structure of catecholamine secretory vesicles from PC12 cells. J. Neurochem. 45, 1244-1253.
36. Wightman R. M., Jankowski J. A., Kennedy R. T., Kawagoe K. T., Schroeder T. J., Leszczyszyn D. J., Near J. A., Diliberto E. J. Jr., and Viveros O. H. (1991) Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells. Proc. Natl. Acad. Sci. USA 88, 10754-10758.